Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Gepotidacin - GSK

Next Previous
Drug Profile

Gepotidacin - GSK

Alternative Names: Blujepa; GSK 2140944; GSK-2140944E

Latest Information Update: 10 Oct 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GSK
  • Class Acenaphthenes; Anti-infectives; Antibacterials; Aza compounds; Ketones; Piperidines; Pyridines; Pyrones; Small molecules; Urinary anti-infective agents
  • Mechanism of Action DNA gyrase inhibitors; DNA topoisomerase IV inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Registered Urinary tract infections
  • Phase III Gonorrhoea
  • Discontinued Respiratory tract infections; Skin and soft tissue infections

Most Recent Events

  • 11 Apr 2025 Antimicrobial data from preclinical trial in Urinary tract infections presented at the 35th Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID-2025)
  • 11 Apr 2025 Pharmacodynamics data from a preclinical trial in Urinary tract infection presented at the 35th Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID-2025)
  • 11 Apr 2025 Efficacy and adverse events data from phase-III EAGLE-J trial in Urinary tract infections presented at the 35th Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID-2025)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top